New Political Economy of Pharmaceuticals

Zaheer Babar, University of Auckland, New ZealandSudip Chaudhuri, Indian Institute of Management Calcutta, IndiaAnwar Gilani, Aga Khan University, PakistanAndy Gray, University of KwaZulu-Natal, South AfricaMohamed Azmi Ahmad Hassali, Universiti Sains MalaysiaChee-Ruey Hsieh, Academia Sinica, TaiwanRichard Husada, Universitas Surabaya, IndonesiaDina Iskander, Oxfam Novib, Cairo, EgyptShazia Qasim Jamshed, International Islamic University, MalaysiaHans Löfgren, Deakin University, AustraliaMuhammad Ashar Malik, Aga Khan University, PakistanShankaran Nambiar, Manipal International University, MalaysiaJens Plahte, Oslo, NorwaySimon Reid-Henry, Queen Mary, University of London, UKAsrul Akmal Shafie, Universiti Sains MalaysiaCassandra Sweet, PUC, Santiago, ChileJayabalan Thambyappa, Academy of Occupational and Environmental Medicine, MalaysiaRaymond R Tjandrawinata, Dexa Laboratories of Biomolecular Sciences, Tangerang, IndonesiaYousuf A Vawda, University of KwaZulu Natal, South AfricaIpek Eren Vural, Middle East Technical University, Ankara, TurkeyOwain David Williams, Aberystwyth University, WalesBong-min Yang, Seoul National University, South Korea

• 1. The New Political Economy of Pharmaceuticals: Conformity and Resistance in the Global South; Owain David Williams and Hans Löfgren 2. The Political Economy of Pharmaceutical Production in Brazil; Cassandra M. Sweet 3. Pharmaceuticals, Health Policy and Intellectual Property Rights in China; Chee-Ruey Hsieh 4. Immunity to TRIPS? Vaccine Production and the Biotechnology Industry in Cuba; Jens Plahte and Simon Reid-Henry 5. TRIPS and Access to Medicines in Egypt; Dina Iskander 6. The Pharmaceutical Industry in India after TRIPS; Sudip Chaudhuri 7. The Health Care System and the Pharmaceutical Industry in Indonesia; Richard Husada and Raymond R. Tjandrawinata 8. TRIPS, Free Trade Agreements and the Pharmaceutical Industry in Malaysia; Mohamed Azmi Hassali, Jayabalan Thambyappa, Shankaran Nambiar and Asrul Akmal Shafie 9. The Pharmaceutical Industry, Intellectual Property Rights and Access to Medicines in Pakistan: Zaheer-Ud-Din Babar, Shazia Jamshed, Ashar Malik and Anwarul-Hassan Gilani 10. TRIPS, Access to Medicines and Local Production in South Africa; Andrew L. Gray and Yousuf A. Vawda 11. TRIPS and New Challenges for the Pharmaceutical Sector in South Korea; Bong-min Yang and Hye-young Kwon 12. Intellectual Property Rights and Neoliberal Restructuring in Turkey: The Pharmaceutical Industry; Ipek Eren Vural 13. Conclusion: TRIPS, Drug Production in the Global South, and Access to Medicines; Hans Löfgren and Owain David Williams